Trial Profile
Risk of postoperative complications in inflammatory bowel disease patients preoperatively treated with vedolizumab: A retrospective cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2019
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 06 Jun 2019 Results published in the Journal of Gastroenterology and Hepatology
- 24 Jul 2017 New trial record
- 18 Jul 2017 Results published in the American Journal of Gastroenterology